Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Oncogene 37 (42), 56665681
Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery
No clinically validated component ratio was identified
While self-administration is feasible with proper training, consulting with healthcare professionals for initial guidance is advisable
A., Jansen, R
This growth is driven by clinical success of approved peptides, expanding applications, and continued pipeline development
US$ 26.12
US$ 20.55
US$ 23.56
US$ 24.41
US$ 26.49
US$ 24.38
US$ 28.61
